Summary sheet
- Industry - Manufacturing
The project will support the research and development (R&D) activities of an EU-based promoter in the medical technology sector, focusing on the development of innovative solutions for precision radiation therapy and radiosurgery addressing unmet needs in oncology care and selected neurological disorders.
The project aims to strengthen the promoter's competitive position in high value added medical technologies by investing in R&D activities focused on precision radiation therapy and radiosurgery, addressing unmet needs in oncology and selected neurological disorders.
The RDI activities are expected to be carried out in existing facilities that are already used for the same purposes and that are not expected to change their scope due to the project. An environmental impact assessment (EIA) is therefore not needed as per EIA Directive 2014/52/EU amending Directive 2011/92/EU. The environmental aspects will be further investigated and confirmed during appraisal. The project is expected to generate social benefits by supporting technological advances in cancer treatment, with the potential to improve treatment effectiveness and patient outcomes, while contributing to innovation and high skilled employment in the medtech sector.
The promoter is a private company, not operating in the utilities sector and does not have the status of a contracting authority; therefore, it is not subject to EU Directives on procurement. Nevertheless, the promoter's procurement procedures are expected to align with EIB guidelines for private sector projects, and the EIB will verify compliance during project due diligence.